Cargando…

Why has MDR-TB prevalence increased in Iran?

Detalles Bibliográficos
Autores principales: Heidary, Mohsen, Nasiri, Mohammad Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850224/
https://www.ncbi.nlm.nih.gov/pubmed/31723691
http://dx.doi.org/10.1016/j.jctube.2016.11.004
_version_ 1783469378100002816
author Heidary, Mohsen
Nasiri, Mohammad Javad
author_facet Heidary, Mohsen
Nasiri, Mohammad Javad
author_sort Heidary, Mohsen
collection PubMed
description
format Online
Article
Text
id pubmed-6850224
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68502242019-11-13 Why has MDR-TB prevalence increased in Iran? Heidary, Mohsen Nasiri, Mohammad Javad J Clin Tuberc Other Mycobact Dis Article Elsevier 2016-11-19 /pmc/articles/PMC6850224/ /pubmed/31723691 http://dx.doi.org/10.1016/j.jctube.2016.11.004 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Heidary, Mohsen
Nasiri, Mohammad Javad
Why has MDR-TB prevalence increased in Iran?
title Why has MDR-TB prevalence increased in Iran?
title_full Why has MDR-TB prevalence increased in Iran?
title_fullStr Why has MDR-TB prevalence increased in Iran?
title_full_unstemmed Why has MDR-TB prevalence increased in Iran?
title_short Why has MDR-TB prevalence increased in Iran?
title_sort why has mdr-tb prevalence increased in iran?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850224/
https://www.ncbi.nlm.nih.gov/pubmed/31723691
http://dx.doi.org/10.1016/j.jctube.2016.11.004
work_keys_str_mv AT heidarymohsen whyhasmdrtbprevalenceincreasediniran
AT nasirimohammadjavad whyhasmdrtbprevalenceincreasediniran